Search Results - "Antiviral agents."

Antiretroviral therapy 2007, new concepts and lessons learned

Table of Contents: “…Contents: Data from recent past about AIDS -- HIV life cycle and mechanisms of action of antiretroviral agents -- Nucleoside-nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs): potency, pharmacokinetics and adverse effects -- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) -- Protease inhibitors (PIs) -- Cell entry inhibitors -- Initiation of antiretroviral therapy in the naive patient -- Health authorities' guidelines for initial therapy -- Key factors for improved durability -- Cell cycle and effect of antiviral agents -- Risks of early treatment -- New directions in antiretroviral therapy.…”
Get full text
Series

Antiretroviral therapy 2007, new concepts and lessons learned

Table of Contents: “…Contents: Data from recent past about AIDS -- HIV life cycle and mechanisms of action of antiretroviral agents -- Nucleoside-nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs): potency, pharmacokinetics and adverse effects -- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) -- Protease inhibitors (PIs) -- Cell entry inhibitors -- Initiation of antiretroviral therapy in the naive patient -- Health authorities' guidelines for initial therapy -- Key factors for improved durability -- Cell cycle and effect of antiviral agents -- Risks of early treatment -- New directions in antiretroviral therapy.…”
Get full text
Series

Antiretroviral therapy 2007, new concepts and lessons learned

Table of Contents: “…Contents: Data from recent past about AIDS -- HIV life cycle and mechanisms of action of antiretroviral agents -- Nucleoside-nucleotide reverse transcriptase inhibitors (NRTIs/NtRTIs): potency, pharmacokinetics and adverse effects -- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) -- Protease inhibitors (PIs) -- Cell entry inhibitors -- Initiation of antiretroviral therapy in the naive patient -- Health authorities' guidelines for initial therapy -- Key factors for improved durability -- Cell cycle and effect of antiviral agents -- Risks of early treatment -- New directions in antiretroviral therapy.…”
Get full text
Series